Other groups of researchers also described decreased expression of NDRG2 gene in tissues from various malignant neoplasms, e.g., in breast cancer [19], liver carcinoma [20], clear cell renal carcinoma [21] and skin carcinoma [22]. This evidence concerns the gene NDRG2 and hepatocellular carcinoma.